Tag: Pacira Pharmaceuticals

  • Mid Cap Bullish Stocks: Zillow Inc (NASDAQ:Z), Incyte Corporation (NASDAQ:INCY), Synaptics, Incorporated (NASDAQ:SYNA), Pacira Pharmaceuticals (NASDAQ:PCRX)

    Zillow Inc (NASDAQ:Z), the leading real estate information marketplace, announced that online marketing and lead management software maker Boston Logic has joined Zillow® Tech Connect. Zillow Tech Connect allows technology companies to partner with Zillow to integrate their systems for the brokers and agents who use Zillow as a key component of their marketing efforts – at no additional cost. Zillow Inc (NASDAQ:Z) shares after opening at $95.11 moved to $104.68 on last trade day and at the end of the day closed at $103.00. Company price to sales ratio in past twelve months was calculated as 20.72 and price to cash ratio as 13.86. Zillow Inc (NASDAQ:Z) showed a positive weekly performance of 18.32%.

    Incyte Corporation (Nasdaq:INCY) announced that it has scheduled its first quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, May 1, 2014.  Incyte Corporation (NASDAQ:INCY) shares advanced 6.53% in last trading session and ended the day on $47.45. INCY return on equity ratio is recorded as 111.10% and its return on assets is -23.90%. Incyte Corporation (NASDAQ:INCY) yearly performance is 118.66%.

    Investment analysts at Sterne Agee initiated coverage on shares of Synaptics (NASDAQ:SYNA) in a note issued to investors on Monday,AnalystRatings.Net reports. The firm set a “buy” rating on the stock. Synaptics, Incorporated (NASDAQ:SYNA) shares moved up 5.58% in last trading session and was closed at $65.63, while trading in range of $62.17-$65.74. Synaptics, Incorporated (NASDAQ:SYNA) year to date performance is 26.67%.

    Pacira Pharmaceuticals Inc (NASDAQ:PCRX) announced that financial results for the company’s first quarter ended March 31, 2014, will be released before the market opens on Thursday, May 1, 2014. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) weekly performance is %. On last trading day company shares ended up $70.03. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) distance from 50-day simple moving average is -0.06%. Analysts mean target price for the company is $86.07.